StockData
Enanta Pharmaceuticals Inc logo

Enanta Pharmaceuticals Inc (ENTA) stock

ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 2/3010% above fair value
$10.67−0.32 (-2.91%)

Close on Nov 16, 2026Market cap $310.77MP/E –Yield –

Enanta Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Enanta Pharmaceuticals's EV/EBITDA was 38.0× on Jul 31, 2020, against 12.8× a year earlier. Over the last 5 years it ranged from 2.7× to 52.4×, with a median of 14.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2020Jul 31, 202038.0×+15.9
2019Dec 31, 201922.1×+10.3
2018Dec 31, 201811.7×−21.9
2017Dec 29, 201733.6×+14.5
2016Dec 30, 201619.1×+15.3
2015Dec 31, 20153.8×−40.4
2014Dec 31, 201444.2×+2.3
2013Dec 31, 201341.9×–

More Enanta Pharmaceuticals figures

See a number that looks wrong?